Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Synthetic Anti-infective Drugs>Antifungal Drugs>Terbinafine Hydrochloride
Terbinafine Hydrochloride
  • Terbinafine Hydrochloride
  • Terbinafine Hydrochloride

Terbinafine Hydrochloride

Price $2
Package 25Kg/Drum
Min. Order: 25Kg/Drum
Supply Ability: 1ton
Update Time: 2019-10-29

Product Details

Product Name: Terbinafine Hydrochloride CAS No.: 78628-80-5
Min. Order: 25Kg/Drum Purity: 99%
Supply Ability: 1ton Release date: 2019/10/29
Introduction
 

 

Terbinafine·HCl a member of the allylamine class of antifungals, has been found to be a specific inhibitor of ergosterol synthesis via squalene epoxidase inhibition. Squalene epoxidase is an enzyme released by the dermatophyte fungi to break down Squalene, which interferes with cell membrane function and wall synthesis. Research has shown that Terbinafine also reduces the ability of fungal pathogens to generate reactive oxygen species, therefore it is noted as a free radical scavenger in vitro and could potentially contain anti-inflammatory activity in vivo.

Additionally, Terbinafine has also been reported to suppress cell proliferation in vitro and in vivo through inhibition of DNA synthesis and apoptosis activation. It has also been noted that by pretreating of cells with a p21 specific antisense oligonucleotide the Terbinafine induced inhibition of cell growth can be reversed. Assays further demonstrated that Terbinafine also contains anti-angiogenic effects in chick embryo chorioallantoic membranes.

Terbinafine is highly active against dermatophytes, mold, other basic fungi, and some strains of yeast. It is clinically used to treat nail and skin infections, inhibiting ergosterol synthesis at the stage of squalene epoxidation (IC50 = 30 nM for C. albicans). At 90-120 µM, terbinafine exhibits anti-tumor and anti-angiogenic activity by inducing cell cycle arrest at the G0/G1 stage in COLO 205 tumor cells and human vascular endothelial cells.
Function

 

1. Terbinafine is mainly effective on the dermatophyte group of fungi.
2. As a 1% cream or powder, it is used topically for superficial skin infections such as jock itch (tinea cruris), athlete's foot (tinea pedis), and other types of ringworm (tinea corporis). Terbinafine cream works in about half the time required by other antifungals.
3. Oral 250-mg tablets are often prescribed for the treatment of onychomycosis, a fungal nail infection, typically by a dermatophyte or Candida species. Fungal nail infections are located deep under the nail in the cuticle to which topically applied treatments are unable to penetrate in sufficient amounts. The tablets may, rarely, cause hepatotoxicity, so patients are warned of this and may be monitored with liver function tests. Alternatives to oral administration have been studied.
4. Terbinafine hydrochloride may induce or exacerbate subacute cutaneous lupus erythematosus. Persons with lupus erythematosus should first discuss possible risks with their doctor before initiation of therapy.

 

Specification                                          

 

 

Items

Specifications

Results

Appearance

White Crystalline Powder

White Crystalline Powder
 

 

Identification

Infared Absorption

Complies

The retention time of the major peak  

 in the chromatogram of the 

Assay prepration corresponds to that in

 the  chromatogram of the standard preparation,

 as obtained in the assay

complies

Specific rotation

Between -28.6°and -35.0°, measured at   20°

-32.8°

Water

not more than 0.5%

0.12%

residue on ignition

not more than 0.2%

0.11%

Heavy metals

not more than 0.001%

complies

related compounds by HPLC(Test1)

Fructose not more than 0.3% Compound   

A not more than 0.3% Other individual  impurity not more than   0.1%                         

 Total   impurities not more than   0.5%                       

Fructose:   0.03%            Compound   A: 0.04%   

Total impurities: 0.07%

Particle size

90% less than 350 microns

complies

Limit of sulfamate and sulfate

Sulfamate ion not more than 0.10%  

  Sulfate ion not more than 0.10%

complies

Residual Solvent

Methylene Chloride not more than   250μg/g

not detected

Acetone not mor than 2500μg/g

Isopropanol not more than 5000μg/g

Ethanenitrile not more than 400μg/g

n-hexane not more than 290μg/g

Ethyl Acetate not more than 2500μg/g

Pyridine not more than 100μg/g

Assay

Topiramate contains not less than   98.0% and 

 not more than the equivalent  of 102.0% of C12H21NO8S, calculated   with  reference to the Anhydrous Basis

99.80%

Conclustion

The material complies with respect to   USP32

Application                              

Anti-fungal, onychomycosis


Anti-tumor and anti-angiogenic 

For athlete's foot,Onychomycosis, tinea, jock itch, tinea versicolor caused by fungi have a significant effect

For bronchial asthma, asthmatic bronchitis and emphysema

Packaging & Shipping

Packaging

Packaging Detail

0.5kgs/Al-foil bag

1.0kgs/Al-foil bag

2.0kgs/Al-foil bag

5.0 kgs/Al-foil bag

25.0 kgs/drum

or upon customers' request.

Article illustration

Company Profile Introduction

You may like

Recommended supplier

Product name Price   Suppliers Update time
$10.00/1KG
VIP4Y
Hebei Guanlang Biotechnology Co,.LTD
2024-07-24
$0.00/1Kg/Bag
VIP4Y
Sinoway Industrial co., ltd.
2024-06-27
$6.00/1kg
VIP1Y
Hebei Longbang Technology Co., Ltd
2024-05-27
$120.00/1kg
VIP1Y
Hebei Zhuanglai Chemical Trading Co.,Ltd
2024-05-16
$0.00/1kg
VIP1Y
Shaanxi TNJONE Pharmaceutical Co., Ltd
2024-05-13
$0.00/1kg
VIP1Y
Henan Suikang Pharmaceutical Co.,Ltd.
2024-04-28
$6.00/1KG
VIP1Y
Hebei Saisier Technology Co., LTD
2024-04-22
$90.00/1kg
VIP2Y
Guangzhou Tengyue Chemical Co., Ltd.
2024-03-19
$35.00/1kg
VIP1Y
Sigma Audley
2024-03-15
$8.00/25kg
VIP1Y
Hebei Jingbo New Material Technology Co., Ltd
2024-01-09
  • Since: 2012-02-03
  • Address: No. 7, No. 7, No. 1, No. 160, Qiaokou Road, Qiaokou District, Qiaokou city.
INQUIRY